Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development of a novel glycoengineering platform for the rapid production of conjugate vaccines

18 Aug 2023

Abstract excerpt

Conjugate vaccines produced either by chemical or biologically conjugation have been demonstrated to be safe and efficacious in protection against several deadly bacterial diseases. However, conjugate vaccine assembly and production have several shortcomings which hinders their wider availability. Here, we developed a tool, Mobile-element Assisted Glycoconjugation by Insertion on Chromosome, MAGIC, a novel...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bacteriophages and microbial interactions
Share to Escherichia coli research studies
Share to Viral gastroenteritis research and epidemiology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37596672
DOI: 10.1186/s12934-023-02125-y

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development of a novel glycoengineering platform for the rapid production of conjugate vaccinesPMID 37596672Read ↗

Development of a novel glycoengineering platform for the rapid production of conjugate vaccinesSemantic proximity Read ↗

Glycoengineered Outer Membrane Vesicles: A Novel Platform for Bacterial VaccinesSemantic proximity Read ↗

A scalable cell-free manufacturing platform for two-step bioproduction of immunogenic conjugate vaccinesSemantic proximity Read ↗

A low-cost recombinant glycoconjugate vaccine confers immunogenicity and protection against enterotoxigenic Escherichia coli infections in miceSemantic proximity Read ↗

Polysaccharide Conjugate Vaccines: From Historical Milestones to Future StrategiesSemantic proximity Read ↗

New Routes and Opportunities for Modular Construction of Particulate Vaccines: Stick, Click, and GlueSemantic proximity Read ↗

Recombinant production platform for Group A Streptococcus glycoconjugate vaccinesSemantic proximity Read ↗

Increased efficiency of Campylobacter jejuni N-oligosaccharyltransferase PglB by structure-guided engineering.Semantic proximity Read ↗

Carbohydrate based meningococcal vaccines: past and present overviewSemantic proximity Read ↗

Outer Membrane Vesicle Vaccine PlatformsSemantic proximity Read ↗

Development of a Promising Bivalent Vaccine Against Klebsiella pneumoniae Based on Glycoengineered GMMA (geGMMA)Semantic proximity Read ↗

A low-cost, thermostable, cell-free protein synthesis platform for on demand production of conjugate vaccinesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.